Skip to main content
. 2019 Jun 14;8(10):e1629261. doi: 10.1080/2162402X.2019.1629261

Figure 4.

Figure 4.

CMTM6 or PD-L1 expression in non-small cell carcinoma. (A) Positive cytoplasmic or membranous CMTM6 expression in tumor cells. (B) Negative CMTM6 expression in tumor cells. (C) Positive membranous SP263 PD-L1 expression in tumor cells. (D) Negative SP263 PD-L1 expression in tumor cells. (E) Positive membranous 22C3 PD-L1 expression in tumor cells. (F) Negative 22C3 PD-L1 expression in tumor cells.